Sort
16,300 grants matching “fatty liver disease”
Role of DGAT in Triacyglycerol Metabolism
$605,638Robert V Farese · J. David Gladstone Institutes · R01 · FY2011 · DK
Metabolic Responses to an Oral Mixed Meal Tolerance Test: Intra-individual changes, correlates, and prognostic significance
$605,469Matthew G. Nayor · Boston University Medical Campus · R01 · FY2022 · HL
Quantification of Liver Fibrosis with MRI and Deep Learning
$605,187Lili He · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · EB
Moderately CHO-restricted diet as treatment targeting improvement in hepatic lipid and insulin sensitivity in adolescents with NAFLD
$605,184Amy Miskimon Goss · University Of Alabama At Birmingham · R01 · FY2021 · DK
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
$604,863Ann Hsing · Stanford University · UH3 · FY2025 · HL
Novel liver-mediated mechanisms in hypertension and cardiac dysfunction
$604,818David E Stec · University Of Mississippi Med Ctr · R01 · FY2025 · HL
The altered lipid and protein metabolism of pediatric patients with HIV infection
$604,778Farook Jahoor · Baylor College Of Medicine · R01 · FY2010 · HD
Project 1 - Determining the contributions of the gut microbiota to the physiologi
$604,630Jeffrey Ivan Gordon · Washington University · P01 · FY2014 · DK
Fully Automated High-Throughput Quantitative MRI of the Liver
$604,446Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2024 · EB
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
$604,426Jean-Marc Schwarz · Touro University Of California · R01 · FY2014 · HL
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis
$604,327Jennifer Y. Chen · University Of California, San Francisco · R01 · FY2025 · DK
Mapping MTP lipid transfer activities for better therapeutics
$604,040M Mahmood Hussain · Nyu Long Island School Of Medicine · R01 · FY2021 · HL
Defining the role of PLA2G12B on apoB-containing lipoprotein assembly, plasma levels, metabolism and cardiovascular disease risk
$603,632Steven A Farber · Johns Hopkins University · R01 · FY2025 · DK
Atheroregression via Enhanced Reverse Choleserol Transport
$603,540Henry J. Pownall · Baylor College Of Medicine · R01 · FY2011 · HL
Glycopathology of HCC: identification of the source cells of serum fucosylation
$603,318Anand S Mehta · Medical University Of South Carolina · U01 · FY2022 · CA
Glycopathology of HCC: identification of the source cells of serum fucosylation
$603,318Anand S Mehta · Medical University Of South Carolina · U01 · FY2023 · CA
Mechanisms of SGLT2 Inhibition in Pediatric NAFLD
$603,223Justin R. Ryder · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · DK
Regulation of Metabolism by FGF21
$603,031Matthew Joseph Potthoff · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · DK
Characterizing the Human Imprint Regulatory Regions Associated with Childhood Obesity
$603,023David Skaar · North Carolina State University Raleigh · R01 · FY2019 · HD
Metabolic regulation and inhibition of ATP-citrate lyase
$602,995Ronen Marmorstein · University Of Pennsylvania · R01 · FY2024 · CA
Exposome and Precision Medicine in NAFLD
$602,978Matthew C Cave · University Of Louisville · R01 · FY2022 · ES
Biology of the orphan receptor Rev-erb alpha
$602,972Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2016 · DK
Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family
$602,955Aras Nikodemas Mattis · University Of California, San Francisco · R01 · FY2025 · DK
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)
$602,699Manal M Hassan · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring
$602,601Teri L Hernandez · University Of Colorado Denver · R01 · FY2018 · DK